The invention relates to a medicine for treating dry eye syndromes. The medicine for treating dry eye syndromes comprises the following components in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of dried ginger, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of angelica dahurica, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of motherwort fruit, 10-20 parts of radix sileris, 15-30 parts of capillary artemisia, 20-30 parts of myrobalan, 1-20 parts of fenugreek, 1-20 parts of celandine, 10-25 parts of rhizoma imperatae, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of semen pharbitidis, 15-20 parts of lychee seed, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of folium rhododendri daurici, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of white mulberry root-bark, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon euryale seed and 10-25 parts of Chinese azalea flower. All the components of the medicine for treating dry eye syndromes are natural materials, so that the medicine for treating the dry eye syndromes has good safety and clear curative effect and is suitable for large-scale application in clinic.